You are here

MHRP Scientists and Collaborators Presenting at CROI 2019

February 28, 2019

MHRP and collaborators will present the following abstracts at the annual Conference on Retroviruses and Opportunistic Infections (CROI) taking place March 4-7 in Seattle (bolded names are MHRP researchers):

Gowoon Son*, “Gender and coinfections contribute to immune activation in treated HIV infection”*

Christina Polyak, “Antiretroviral regimen durability is not driven by viral failure in an African cohort"

Linda Jagodzinski, “Detection of cell-associated HIV-1 nucleic acid in blood after early ART"

Alexandra Schuetz, “Early ART partly reduces HIV-induced mucosal B-cell hyperactivation"

Bianca Schulte, “Comparative analysis of the magnitude and quality of vaccine-elicited T-cell response"

Siriwat Akapirat, “Long boost intervals of ALVAC-HIV/AIDSVAX B/E increased genital HIV env IGG responses"

Caroline Subra, “CSF HIV-specific T cells persist during ART and associate with lower CNS inflammation"

Trevor Crowell, "Viral blips after treatment initiation during acute HIV infection"

Vishakha Sharma, "Shiv gene expression in CSF CD4 T cells during acute infection of rhesus macaques"

Julie Mitchell, "HIV-specific antibody levels correlate with Tfh maturation in early treated infants"

Supranee Buranapraditkun, "Effect of Telmisartan given at ART initiation in AHI on immune cells in lymph nodes"

Donn Colby, "Anogenital HIV detected during analytic treatment interruption in remission trials"

Carissa Philippi, "Resting-state connectivity associates with depression symptoms in acute HIV"

Ryan Handoko, "Minimal incidence of CSF escape after initiation of ART in acute HIV infection"

Philip Chan*, "Neuropsychiatric outcomes before and after switching to Dolutegravir-based therapy"

Michelle D'Antoni, "Early ART in acute HIV limits detrimental CX3CR1 monocytes linked to CNS dysfunction"

Michael Corley, "Capturing DNA methylation changes in monocytes when initiating ART early in acute HIV"

Morgane Rolland, "VRC01 epitope motifs predicted rebound kinetics after VRC01/treatment interruption"

* - themed discussion